Arcellx Inc

ACLX remains in a Stage 2 advancing environment following the Momentum Breakout, anchoring a bullish medium-term bias. However, price is extended above the rising EMAs and RSI sits in overbought territory, making immediate entry unfavorable. Execution should be deferred, stalking for pullbacks into the rising 9/21EMA or the 50DMA. The long-term uptrend remains intact, but failure of EMAs to hold could trigger a deeper retracement.

• ↑$115 cash offer values Arcellx at ~$7.8B, signaling strategic premium
• ↑$5 CVR tied to achieving $6B anito-cel sales by 2029
• ↓Achieving $6B cumulative sales by 2029 poses high execution risk